Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay

Journal of Clinical Microbiology

Volumn 37, Issue 8, 1999, Pages 2663-2666

  Hirano, Kazue ^a   Abe, Chiyoji ^a   Takahashi, Mitsuyoshi ^a  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ARTICLE; ASIA; ASSAY; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; EARLY DIAGNOSIS; GENE MUTATION; GENE SEQUENCE; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; PROKARYOTA; RICKETTSIALES;

EID: 0032793713     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.8.2663-2666.1999     Document Type: Article

References (37)

1. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. Sun Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
2. Barnes, P. F., A. B. Bloch, P. T. Davidson, and D. E. Snider, Jr. 1991. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 324:1644-1650.
3. Bass, J. B., Jr., L. S. Farer, P. C. Hopewell, R. O'Brien, R. F. Jacobs, F. Ruben, D. E. Snider, Jr., and G. Thornton. 1994. Treatment of tuberculosis and tuberculosis infection in adults and children. Am. J. Respir. Crit. Care Med. 149:1359-1374.
4. Belanger, A. E., G. S. Besra, M. E. Ford, K. Mikusova, J. T. Belisle, P. J. Brennan, and J. M. Inamine. 1996. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc. Natl. Acad. Sci. USA 93:11919-11924.
5. Cambau, E., W. Sougakoff, M. Besson, C. Truffot-Pernot, J. Grosset, and V. Jarlier. 1994. Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. J. Infect. Dis. 170:479-483.
6. Canetti, G. 1965. Present aspects of bacterial resistance in tuberculosis. Am. Rev. Respir. Dis. 92:687-703.
7. Centers for Disease Control. 1991. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. Morbid. Mortal. Weekly Rep. 40:585-591.
8. Cooksey, R. C., G. P. Morlock, S. Glickman, and J. T. Crawford. 1997. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J. Clin. Microbiol. 35:1281-1283.
9. Dooley, S. W., W. R. Jarvis, W. J. Marlone, and D. E. Snider. 1992. Multidrug-resistant tuberculosis. Ann. Intern. Med. 117:257-259.
10. Finken, M., P. Kirschner, A. Meier, A. Wrede, and E. C. Bottger. 1993. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol. Microbiol. 9:1239-1246.
11. Goble, M., M. D. Iseman, L. A. Madsen, D. Waite, L. Ackerson, and C. R. Horsburgh. 1993. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N. Engl. J. Med. 328:527-532.
12. Herrera, D., R. Cano, P. Godoy, E. F. Peiro, J. Castell, C. Ibanez, F. Martinez Navarro. 1996. Multidrug-resistant tuberculosis outbreak on an HIV ward - Madrid, Spain, 1991-1995. Morbid. Mortal. Weekly Rep. 45:330-333.
13. Heym, B., N. Honore, C. Truffot-Pernot, A. Banerjee, C. Schurra, W. R. Jacobs, Jr., J. D. A. van Embden, J. H. Grosset, and S. T. Cole. 1994. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 344:293-298.
14. Hirano, K., M. Takahashi, Y. Kazumi, Y. Fukasawa, and C. Abe. 1998. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle Lung Dis. 78:117-122.
15. Jin, D. J., and C. A. Gross. 1988. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 202:45-58.
16. Jin, D. J., and C. A. Gross. 1989. Characterization of the pleiotrophic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli. J. Bacteriol. 171:5229-5231.
17. Katsukawa, C., A. Tamaru, Y. Miyata, C. Abe, M. Makino, and Y. Suzuki. 1997. Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolates of Mycobacterium tuberculosis in Japan. J. Appl. Microbiol. 83:634-640.
18. Konno, K., F. M. Feldmann, and W. McDermott. 1967. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am. Rev. Respir. Dis. 95:461-469.
19. Mahmoudi, A., and M. D. Iseman. 1993. Pitfalls in the care of patients with tuberculosis. JAMA 270:65-68.
20. McClatchy, J. K., A. Y. Tsang, and M. S. Cernich. 1981. Use of pyrazinamidase activity in Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob. Agents Chemother. 20: 556-557.
21. Monno, L., G. Angarano, S. Carbonara, S. Coppola, D. Costa, M. Quarto, and G. Pastore. 1991. Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients. Lancet 337:852.
22. Nair, J., D. A. Rouse, G.-H. Bai, and S. L. Morris. 1993. The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis. Mol. Microbiol. 10:521-527.
23. Pablos-Mendez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rieder, F. Bustreo, D. L. Cohn, C. S. B. Lambregts-van Weezenbeek, S. J. Kim, P. Chaulet, and P. Nunn. 1998. Global surveillance for antituberculosis-drug resistance, 1994-1997. N. Engl. J. Med. 338:1641-1649.
24. Rossau, R., H. Traore, H. de Beenhouwer, W. Mijs, G. Jannes, P. de Rijk, and F. Portaels. 1997. Evaluation of the INNO-LiPA Rif.TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother. 41:2093-2098.
25. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
26. Snider, D. E., and W. L. Roper. 1992. The new tuberculosis. N. Engl. J. Med. 326:703-705.
27. Sreevatsan, S., K. E. Stochbauer, X. Pan, B. N. Kreiswirth, S. L. Moghazen, W. R. Jacobs, Jr., A. Telenti, and J. M. Musser. 1997. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob. Agents Chemother. 41:1677-1681.
28. Suzuki, Y., C. Katsukawa, K. Inoue, Y. P. Yin, H. Tasaka, N. Ueda, and M. Makino. 1995. Mutations in rpoB gene of rifampicin resistant clinical isolates of Mycobacterium tuberculosis in Japan. J. Jpn. Assoc. Infect. Dis. 69:413-419.
29. Suzuki, Y., C. Katsukawa, A. Tamaru, C. Abe, M. Makino, Y. Mizuguchi, and H. Taniguchi. 1998. Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J. Clin. Microbiol. 36:1220-1225.
30. Taniguchi, H., B. Chang, C. Abe, Y. Nikaido, Y. Mizuguchi, and S. Yoshida. 1997. Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system. J. Bacteriol. 179:4795-4801.
31. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. T. Cole, M. J. Colston, L. Matter, K. Schoolfer, and T. Bodmer. 1993. Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
32. Watterson, S. A., S. M. Wilson, M. D. Yates, and F. A. Drobniewski. 1998. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 34:1969-1973.
33. Williams, D. L., C. Waguespack, K. Eisenach, J. T. Crawford, F. Portaels, M. Salfinger, C. M. Nolan, C. Abe, V. Sticht-Groh, and T. P. Gillis. 1994. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.
34. World Health Organization. 1994. Tuberculosis programme: framework for effective tuberculosis control. Publication no. WHO/TB/94.179. World Health Organization, Geneva, Switzerland.
35. World Health Organization/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. 1998. Anti-tuberculosis drug resistance in the world. Publication no. WHO/TB/97.229. World Health Organization, Geneva, Switzerland.
36. World Health Organization/IUATLD Global Working Group on Antituberculosis Drug Resistance Surveillance. 1997. Guidelines for surveillance of drug resistance in tuberculosis. Publication no. WHO/TB/96.216. World Health Organization, Geneva, Switzerland.
37. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.